CADE approves pharma merger with restrictions
Friday, 11 June 2010
Brazil’s Council for Economic Defence (CADE) has approved French pharmaceutical company Sanofi-Aventis's purchase of Brazilian generics group Medley, on the condition that they divest three drugs.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top